NeuBase Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBSE and other ETFs, options, and stocks.

About NBSE

NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. 

CEO
Todd P. Branning
CEOTodd P. Branning
Employees
37
Employees37
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2009
Founded2009
Employees
37
Employees37

NBSE Key Statistics

Market cap
1.68M
Market cap1.68M
Price-Earnings ratio
-0.05
Price-Earnings ratio-0.05
Dividend yield
Dividend yield
Average volume
389.67K
Average volume389.67K
High today
$0.455
High today$0.455
Low today
$0.403
Low today$0.403
Open price
$0.4251
Open price$0.4251
Volume
284.61K
Volume284.61K
52 Week high
$5.40
52 Week high$5.40
52 Week low
$0.403
52 Week low$0.403
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.